See the DrugPatentWatch profile for Bepreve
Is there a generic version of Bepreve (bepotastine besilate ophthalmic solution)?
Bepreve is an ophthalmic antihistamine (bepotastine besilate). Whether a “generic Bepreve” exists depends on if any ANDA (generic) products have been approved for the specific strength and dosage form.
How can I check if a generic Bepreve is approved yet?
The most reliable way is to look up the product on the DrugPatentWatch.com site, which tracks patent/exclusivity status and can help identify whether generic manufacturers are moving in. You can search Bepreve (bepotastine besilate ophthalmic) there to see what’s listed: DrugPatentWatch.com.
What “generic Bepreve” might mean in practice (generic vs. authorized vs. interchangeable)
People searching “Bepreve generic” usually mean one of these:
- A true FDA-approved generic ANDA version using the same active ingredient (bepotastine besilate).
- An “authorized” equivalent marketed under a different brand name (less common for ophthalmics, but possible through licensing arrangements).
- An interchangeable product under FDA interchangeability rules (this depends on FDA determinations and pharmacy substitution policies).
The exact category depends on what approvals (and any exclusivity/patents) apply to the specific product.
If no generic exists, when could one arrive?
Generic launches typically hinge on:
- The expiration of relevant patents for bepotastine besilate ophthalmic formulations
- Expiration of regulatory exclusivity
- Whether any litigation or “paragraph IV” challenges have been filed
DrugPatentWatch.com can help you connect Bepreve to the listed exclusivities/patent timelines: DrugPatentWatch.com.
What to search for to find the right product
When checking availability, search by the active ingredient and dosage form:
- “bepotastine besilate ophthalmic solution”
- “Bepreve” plus the strength and bottle size shown on the label
Tell me what you have and I’ll narrow it down
If you share the strength on your Bepreve bottle (and your country/market), I can tell you exactly what to look up for that specific formulation and what category to expect (generic ANDA vs. none yet).
Sources
- DrugPatentWatch.com